Lamprecid structure
|
Common Name | Lamprecid | ||
---|---|---|---|---|
CAS Number | 88-30-2 | Molecular Weight | 207.107 | |
Density | 1.6±0.1 g/cm3 | Boiling Point | 307.5±42.0 °C at 760 mmHg | |
Molecular Formula | C7H4F3NO3 | Melting Point | 76-79 °C(lit.) | |
MSDS | Chinese USA | Flash Point | 139.8±27.9 °C | |
Symbol |
GHS07 |
Signal Word | Warning |
Name | 4-Nitro-3-(trifluoromethyl)phenol |
---|---|
Synonym | More Synonyms |
Density | 1.6±0.1 g/cm3 |
---|---|
Boiling Point | 307.5±42.0 °C at 760 mmHg |
Melting Point | 76-79 °C(lit.) |
Molecular Formula | C7H4F3NO3 |
Molecular Weight | 207.107 |
Flash Point | 139.8±27.9 °C |
Exact Mass | 207.014328 |
PSA | 66.05000 |
LogP | 3.10 |
Vapour Pressure | 0.0±0.7 mmHg at 25°C |
Index of Refraction | 1.507 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H302-H312-H315-H319-H332-H335 |
Precautionary Statements | P261-P280-P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xn: Harmful;Xi: Irritant; |
Risk Phrases | R20/21/22 |
Safety Phrases | S26-S28-S36/37/39-S45 |
RIDADR | 2588 |
WGK Germany | 3 |
RTECS | GP3520000 |
Packaging Group | III |
Hazard Class | 6.1(b) |
HS Code | 2908999090 |
~88% Lamprecid CAS#:88-30-2 |
Literature: Journal of Organic Chemistry, , vol. 63, # 13 p. 4199 - 4208 |
~% Lamprecid CAS#:88-30-2 |
Literature: Tetrahedron Letters, , vol. 45, # 26 p. 5131 - 5133 |
~% Lamprecid CAS#:88-30-2 |
Literature: Bulletin des Societes Chimiques Belges, , vol. 39, p. 298,306, 307 |
~% Lamprecid CAS#:88-30-2 |
Literature: Bulletin des Societes Chimiques Belges, , vol. 39, p. 298,306, 307 |
Precursor 4 | |
---|---|
DownStream 8 | |
HS Code | 2908999090 |
---|---|
Summary | 2908999090 halogenated, sulphonated, nitrated or nitrosated derivatives of phenols or phenol-alcohols。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:5.5%。General tariff:30.0% |
Effect of fenofibrate on retinal neurodegeneration in an experimental model of type 2 diabetes.
Acta Diabetol. 52(1) , 113-22, (2015) There is now consistent evidence from two major clinical trials (the Fenofibrate Intervention and Event Lowering in Diabetes and the Action to Control Cardiovascular Risk in Diabetes Eye) that fenofib... |
|
An RNA binding protein promotes axonal integrity in peripheral neurons by destabilizing REST.
J. Neurosci. 34(50) , 16650-61, (2014) The RE1 Silencing Transcription Factor (REST) acts as a governor of the mature neuronal phenotype by repressing a large consortium of neuronal genes in non-neuronal cells. In the developing nervous sy... |
|
Stiffening hydrogels for investigating the dynamics of hepatic stellate cell mechanotransduction during myofibroblast activation.
Sci. Rep. 6 , 21387, (2016) Tissue fibrosis contributes to nearly half of all deaths in the developed world and is characterized by progressive matrix stiffening. Despite this, nearly all in vitro disease models are mechanically... |
m-Cresol, α,α,α-trifluoro-4-nitro- |
α,α,α-Trifluoro-4-nitro-m-cresol |
WNR DQ BXFFF |
3-06-00-01328 (Beilstein Handbook Reference) |
EINECS 201-818-2 |
MFCD00014714 |
Phenol, 4-nitro-3-(trifluoromethyl)- |
5-Hydroxy-2-nitrobenzotrifluoride |
Lamprecid |
Lamprecide |
4-Nitro-3-(trifluoromethyl)phenol |
Lamprecid 2770 |